World's Best Scientists 2026 revealed!
Jack T. Stapleton

Jack T. Stapleton

D-Index & Metrics

Immunology

D-Index
64
Citations
18798
World Ranking
2903
National Ranking
1369

Jack T. Stapleton publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jack T. Stapleton sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 231 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jack T. Stapleton D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jack T. Stapleton sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jack T. Stapleton is a researcher affiliated with the University of Iowa in the United States. Their work spans multiple areas within medicine, immunology, and microbiology, with a strong focus on infectious diseases and molecular biology.

The scientist has contributed extensively to topics involving HIV research and treatment, mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 research, extracellular vesicles in disease, HIV-related health complications and treatments, viral infections and vectors, as well as immunotherapy and immune responses.

Stapleton has published in a variety of journals, frequently appearing in venues such as The Journal of Infectious Diseases, bioRxiv (Cold Spring Harbor Laboratory), Vaccine, AIDS, and Clinical Infectious Diseases.

Some notable recent papers include:

  • Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae, 2023, Archives of Virology
  • A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS, 2020, Vaccine
  • Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease, 2020, Clinical Infectious Diseases
  • Glycerol Monolaurate, an Analogue to a Factor Secreted by Lactobacillus, Is Virucidal against Enveloped Viruses, Including HIV-1, 2020, mBio
  • Electrostatic Surface Properties of Blood and Semen Extracellular Vesicles: Implications of Sialylation and HIV-Induced Changes on EV Internalization, 2020, Viruses

Frequent co-authors in Stapleton's collaborations include Jinhua Xiang, Patricia Winokur, Chioma M. Okeoma, Sharon E. Frey, and Jennifer L. Welch.

Their research contributions are primarily situated within the following fields of study:

  • Medicine
  • Immunology and Microbiology

Within those fields, subfields emphasized in their work include infectious diseases, molecular biology, immunology, epidemiology, and virology.

Best Publications

  • Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource

    Donald B. Smith;Jens Bukh;Carla Kuiken;A. Scott Muerhoff

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • ICTV Virus Taxonomy Profile: Flaviviridae.

    Peter Simmonds;Paul Becher;Jens Bukh;Ernest A. Gould

  • A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts

    Henry H. Balfour;Beverly A. Chace;Jack T. Stapleton;Richard L. Simmons

  • Efficacy Results of a Trial of a Herpes Simplex Vaccine

    Robert B. Belshe;Peter A. Leone;David I. Bernstein;Anna Wald

  • Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

    Warner K. Huh;Elmar A. Joura;Anna R. Giuliano;Ole Erik Iversen;Ole Erik Iversen

  • Effect of coinfection with GB virus C on survival among patients with HIV infection.

    Jinhua Xiang;Sabina Wünschmann;Daniel J. Diekema;Donna Klinzman

  • The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae

    Jack T. Stapleton;Steven Foung;A. Scott Muerhoff;Jens Bukh;Jens Bukh

  • Persistent GB virus C infection and survival in HIV-infected men.

    Carolyn F. Williams;Donna Klinzman;Traci E. Yamashita;Jinhua Xiang

  • Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor

    Sabina Wünschmann;Jheem D. Medh;Donna Klinzmann;Warren N. Schmidt

  • Proposed revision to the taxonomy of the genus Pestivirus, family Flaviviridae.

    Donald B. Smith;Donald B. Smith;Gregor Meyers;Jens Bukh;Ernest A. Gould

  • Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1

    Jinhua Xiang;Sarah L George;Sabina Wünschmann;Qing Chang

  • Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

    S. Rachel Skinner;S. Rachel Skinner;Anne Szarewski;Barbara Romanowski;Suzanne M. Garland

  • GB virus type C/Hepatitis G virus.

    Jack T. Stapleton

  • Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

    Cosette M Wheeler;S Rachel Skinner;S Rachel Skinner;M Rowena Del Rosario-Raymundo;Suzanne M Garland

  • GB virus C: the good boy virus?

    Nirjal Bhattarai;Jack T. Stapleton

  • Concealment of homosexual identity, social support and CD4 cell count among HIV-seropositive gay men.

    Philip M Ullrich;Susan K Lutgendorf;Jack T Stapleton

  • Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family.

    Donald B. Smith;Paul Becher;Jens Bukh;Ernest A. Gould

  • Immunoglobulin Prophylaxis for Hepatitis A

    Patricia L. Winokur;Jack T. Stapleton

  • Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4 positive T cells

    Jinhua Xiang;Sabina Wünschmann;Warren Schmidt;Jack Stapleton

  • Host Immune Response To Hepatitis A Virus

    Jack T. Stapleton

Frequent Co-Authors

Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Peter Simmonds
Peter Simmonds University of Oxford
Mark J. Mulligan
Mark J. Mulligan New York University
Nadine Rouphael
Nadine Rouphael Emory University
Sharon E. Frey
Sharon E. Frey Saint Louis University
Michael P. Busch
Michael P. Busch University of California, San Francisco
David I. Bernstein
David I. Bernstein University of Cincinnati
Jens Bukh
Jens Bukh University of Copenhagen
David R. Soll
David R. Soll University of Iowa
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing complementary nursing degrees can open new doors in healthcare. Many professionals start with foundation programs like absn programs with high acceptance rates, which provide a fast track for non-nurses to earn their Bachelor of Science in Nursing.

After obtaining an RN, further studies via online RN programs for non nurses offer flexible options for individuals transitioning from other fields. These programs help develop core nursing skills essential for supporting immunology-related patient care and research.

Nurse practitioners can advance their careers by enrolling in an accelerated NP program, designed for nurses aiming to become nurse practitioners quickly while maintaining high-quality education standards. Specializing further, acquiring an acute care NP certification enables nurses to manage complex and critical care patients, often intersecting with immunological disorders.

These pathways illustrate how diverse educational options support career growth in immunology and healthcare, making it easier for both new and experienced professionals to contribute meaningfully in this vital field.

Best Scientists Citing Jack T. Stapleton

Trending Scientists

Recently Published Articles